Renal Denervation Industry

The global renal denervation market size is anticipated to reach USD 3.62 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 40.2% from 2024 to 2030. Growing incidences of hypertension, changing lifestyle, and enduring effect of renal denervation procedure are the key factors driving market.

Increasing cases of uncontrolled and drug-resistant hypertension are expected to fuel the demand for renal denervation. As per the data published in November 2016, by the Centre for Disease Control and Prevention (CDC), about 75 million people in U.S. have high blood pressure. High blood pressure increases the risk of stroke and heart disease, a leading cause of deaths in America. Complications of hypertension causes 9.4 million deaths each year. Furthermore, hypertension is responsible for at least 51% of deaths due to stroke and 45% of deaths due to heart disease.

The renal denervation market in developed economies, such as U.K., France, and Italy, is comparatively mature owing to the presence of key companies in these countries and high demand for such products. Europe commanded the largest share owing to the rise in number of drug-resistant hypertension cases and technological advancements.

On the other hand, developing countries of Asia and Latin America are expected to witness the fastest growth due to economic growth and increased consumer disposable income. Further, growing elderly population coupled with high prevalence of diabetes in these region sis anticipated to propel the region’s development.

Curious about the Renal Denervation Market, Download your FREE sample copy now and get a sneak peek into the latest insights and trends.

Renal Denervation Market Segments Highlights:

  • Radiofrequency based technology dominated the market with a 74.6% share in 2023, primarily due to its effectiveness and advancements in treating resistant hypertension. 
  • Ultrasound renal denervation is expected to register the fastest CAGR during the forecast period owing to its enhanced safety and efficacy compared to other methods. 
  • Europe renal denervation market secured the dominant share with 45.6% of the global revenue in 2023 owing to the high prevalence of hypertension and cardiovascular diseases.

Renal Denervation Market Report Segmentation

Grand View Research has segmented the global renal denervation market report based on technology, and region:

Renal Denervation Technology Outlook (Revenue, USD Million, 2018 - 2030)

  • Radiofrequency based
  • Ultrasound based
  • Micro-Infusion based

Renal Denervation Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • UAE
    • South Africa
    • Kuwait
    • Saudi Arabia

Key Renal Denervation Company Insights

  • Medtronic
  • Abbott
  • Ablative Solutions, Inc
  • Mercator MedSystems, Inc.
  • Otsuka Medical Devices Co., Ltd.
  • Boston Scientific Corporation
  • SympleSurgical, Inc.
  • Johnson & Johnson Services, Inc.

Order a free sample PDF of the Renal Denervation Market Intelligence Study, published by Grand View Research.